Skip to main content
Entheon Biomedical Corp. logo

Entheon Biomedical Corp. — Investor Relations & Filings

Ticker · ENBI ISIN · CA29383X2023 LEI · 894500N2J7IXCCDRWU50 CSE Professional, scientific and technical activities
Open in API
Filings indexed 243 across all filing types
Latest filing 2022-04-29 Interim / Quarterly Rep…
Country CA Canada
Listing CSE ENBI

About Entheon Biomedical Corp.

https://www.entheonbiomedical.com/

Entheon Biomedical Corp. is a biotechnology research and development company focused on creating therapeutic solutions for addiction and substance use disorders. The company specializes in the development and commercialization of psychedelic medicines, particularly dimethyltryptamine (DMT). Entheon aims to progress psychedelics to therapeutics by engineering proprietary drug discovery platforms, innovative drug delivery systems, and novel compounds tailored for treating these complex conditions.

Recent filings

Filing Released Lang Actions
Interim financial statements/report – English.pdf
Interim / Quarterly Report Classification · 100% confidence The document is titled 'CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS FOR THE THREE MONTHS ENDED FEBRUARY 28, 2022 AND 2021' and contains detailed unaudited financial statements including statements of financial position, comprehensive loss, changes in equity, and cash flows for a three-month period. It explicitly states it is prepared in accordance with IAS 34 – Interim Financial Reporting, which is the standard for interim reports. The document is approximately 15,000 characters long, indicating it is a full report rather than a brief announcement. There is no indication that this is an annual report or a certification or an announcement of a report. Therefore, this document fits the definition of an Interim / Quarterly Report (IR).
2022-04-29 English
ON form 13-502F1 (class 1 and 3B reporting issuers - participation fee).pdf
AGM Information Classification · 100% confidence The document is a Notice of Annual General Meeting (AGM) of shareholders, detailing the date, time, location, agenda items including receiving financial statements, electing directors, appointing auditors, and voting instructions. It explicitly states it is a Notice of AGM and includes proxy information. The document length is short (3256 characters) and it does not contain actual financial statements or detailed financial data, but rather information about the meeting and voting procedures. Therefore, it fits the category of AGM Information (AGM-R).
2022-04-27 English
AB form 13-501F1 (class 1 and 3B reporting issuers - participation fee).pdf
Regulatory Filings Classification · 95% confidence The document is a Form 13-501F1, which is a management certification related to participation fees for reporting issuers. It includes officer certification by the CFO, Brandon Schwabe, certifying the completeness and accuracy of the form submitted to the Alberta Securities Commission. The content focuses on market values, securities outstanding, and fee calculations rather than financial results or operational performance. It is primarily a regulatory filing with a certification component, not a full financial report or earnings release. Therefore, it fits best under Regulatory Filings (RNS) as it is a compliance document with officer certification and no substantive financial statements or analysis.
2022-04-27 English
ON form 13-502F1 (class 1 and 3B reporting issuers - participation fee).pdf
Regulatory Filings Classification · 95% confidence The document is titled 'FORM 13-502F1 CLASS 1 AND CLASS 3B REPORTING ISSUERS – PARTICIPATION FEE' and includes a 'MANAGEMENT CERTIFICATION' section. It is a form submitted to the Ontario Securities Commission (OSC) related to participation fees for reporting issuers. The content includes certification by an officer (CFO), market value calculations of securities, and fee calculations. There are no financial statements, earnings data, or detailed management discussion. The document is primarily a regulatory form with officer certification and fee calculation details, not a financial report or earnings release. It fits best under Regulatory Filings (RNS) as it is a compliance filing with a securities regulator and includes a certification statement by an officer.
2022-04-27 English
News release - English.pdf
Capital/Financing Update Classification · 100% confidence The document is a press release announcing a non-brokered private placement financing by Entheon Biomedical Corp. It details the terms of the financing, including the number of units, price, warrants, and intended use of proceeds. There is no financial statement or detailed financial report included. The document is an update on capital raising activity, not a full financial report or earnings release. It is also not a regulatory filing or certification. The content fits the definition of a Capital/Financing Update (CAP) as it provides information on company fundraising and capital structure changes.
2022-04-05 English
52-109FV1 - Certification of annual filings - CEO (E).pdf
Regulatory Filings Classification · 95% confidence The document is a Form 52-109FV1, which is a certification of annual filings by a venture issuer's CEO. It certifies the review and fair presentation of the annual filings, including the annual financial statements and MD&A, for the financial year ended November 30, 2021. The document is a certification letter rather than the actual annual report or financial statements. It explicitly states it is a certification and does not contain substantive financial data or the full report itself. According to the Certification Rule, such officer certifications should be classified as Regulatory Filings (RNS) rather than as the report they reference (e.g., 10-K or Annual Report). The document length is 3152 characters, which is relatively short and consistent with a certification letter rather than a full report.
2022-03-30 English

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.